Pharmacokinetics of neratinib during coadministration with lansoprazole in healthy subjects. (Record no. 26419030)

MARC details
000 -LEADER
fixed length control field 01339 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517114615.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201801s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1365-2125
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1111/bcp.13132
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Keyvanjah, Kiana
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20180105
245 00 - TITLE STATEMENT
Title Pharmacokinetics of neratinib during coadministration with lansoprazole in healthy subjects.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. British journal of clinical pharmacology
Date of publication, distribution, etc. 03 2017
300 ## - PHYSICAL DESCRIPTION
Extent 554-561 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cross-Over Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Interactions
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Healthy Volunteers
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lansoprazole
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proton Pump Inhibitors
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quinolines
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name DiPrimeo, Daniel
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Li, Ai
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Obaidi, Mohammad
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Swearingen, Dennis
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wong, Alvin
773 0# - HOST ITEM ENTRY
Title British journal of clinical pharmacology
Related parts vol. 83
-- no. 3
-- p. 554-561
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1111/bcp.13132">https://doi.org/10.1111/bcp.13132</a>
Public note Available from publisher's website

No items available.